Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 2
2012 1
2013 2
2016 1
2020 2
2021 1
2023 2
2024 2
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.
Chen SY, Xu PP, Feng R, Cui GH, Wang L, Cheng S, Mu RJ, Zhang HL, Wei XL, Song YP, Ding KY, Dong LH, Zhu ZM, Yang SM, Wang X, Liu TB, Hu JD, Zheng XY, Bai O, Xu JY, Huang L, Sang W, Shi KQ, Zhou F, Li F, Liang AB, Zhou H, Hao SG, Huang HH, Xu B, Qian WB, Li CX, Li ZM, Wu CY, Wang XB, Shi WY, Wang SY, Tian YY, Zhang X, Zhou KS, Cui LJ, Liu H, Tan H, Leng Q, Zhao DL, Niu T, Zhao WL. Chen SY, et al. Among authors: zheng xy. Cancer Commun (Lond). 2025 Aug;45(8):919-935. doi: 10.1002/cac2.70033. Epub 2025 May 8. Cancer Commun (Lond). 2025. PMID: 40344323 Free PMC article.
Development and validation of a novel modified cancer cachexia index in patients with locally advanced gastric cancer undergoing neoadjuvant chemotherapy: a multicenter cohort study.
Zhang LK, Zheng HL, Zheng XY, Xu BB, Tang YH, Zheng ZW, Zheng HH, Lin GT, Li P, Zheng CH, Huang CM, Xie JW. Zhang LK, et al. Among authors: zheng xy. Int J Surg. 2025 Sep 1;111(9):5868-5881. doi: 10.1097/JS9.0000000000002707. Epub 2025 Jun 20. Int J Surg. 2025. PMID: 40503786 Free PMC article.
[A Retrospective Study on the Efficacy and Safety of Idarubicin Combined with High-Dose Cytarabine Consolidation in Patients with Acute Myeloid Leukemia over 60 Years of Age in First Remission].
Cao J, Ye YZ, Zheng XY, Chen Y, Luo LT, Zheng J, Yang T, Hu JD. Cao J, et al. Among authors: zheng xy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):671-676. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.009. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37356925 Chinese.
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.
Cai MC, Cheng S, Wang X, Hu JD, Song YP, Huang YH, Yan ZX, Jiang YJ, Fang XS, Zheng XY, Dong LH, Ji MM, Wang L, Xu PP, Zhao WL. Cai MC, et al. Among authors: zheng xy. Genome Med. 2020 Apr 30;12(1):41. doi: 10.1186/s13073-020-00739-0. Genome Med. 2020. PMID: 32349779 Free PMC article. Clinical Trial.
18 results